ORTEXORTEX News
Tracking ASTS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AS
Trader NoteASTS

ASTS Heads Into Earnings Week With Index Flow Looming and Bears Still Dug In

By ORTEX News · Edited by , Editor, ORTEX News4 min readdata as of 3 Nov 2026, 17:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

AST SpaceMobile enters earnings week on the back foot. The stock fell 11% on Monday to $36.33, extending a 38% monthly decline, and it now sits nearly in the centre of a collision between structural short selling, imminent index mechanics, and a next print due in six days.

The positioning picture is dense with short sellers. Short interest is 23.2% of free float, or roughly 64.4 million shares, and while that level has eased about 4% over the past month it remains one of the higher readings in the market. Availability in the lending pool is tight but not fully closed: around 14.5% of shares remain available to borrow, up from a 52-week trough of just 0.3% seen in late September and early October when the pool was essentially exhausted. That loosening partly reflects shares returning to the pool as the stock fell sharply. Cost to borrow, at 1.15%, has drifted 19% lower over the past month, consistent with slightly easier supply rather than intensifying demand. The options market is calm by comparison. The put/call ratio is 0.53, only modestly above its 20-day mean of 0.51 and well below the 52-week high of 0.67, suggesting options traders are not scrambling for downside protection despite the stock's rough October.

The analyst community is split, and recent moves have gone in both directions within weeks of each other. Piper Sandler cut its rating to Neutral from Overweight on October 13, slashing its target from $98 to $54. Deutsche Bank went the other way on October 12, upgrading to Buy while holding its target at $93. Scotiabank followed on October 23 with an upgrade to Sector Outperform and a target of $55.70. The mean price target across the Street sits at $78.48, implying roughly 116% upside from current levels, though that figure is anchored by pre-decline targets and should be read with caution given the speed of the stock's recent fall. The bull case rests on BlueBird constellation progress, government contract wins, and a management-backed 2027 revenue floor of around $500 million. Bears point to cash burn (free cash flow of negative $695 million in Q2), loss-making operations, spectrum interference risk, and potential dilution. The ORTEX short score is 73.6, placing the stock in roughly the 2nd percentile for short-side risk across the universe. EPS momentum scores are exceptionally strong (94th percentile over 30 days, 99th over 90 days), pointing to upward estimate revisions, though that sits oddly against a deeply negative earnings yield at the 15th percentile.

The strategic ownership register is one of the most unusual features of this stock. AT&T holds a 13D stake at 2.7%, Vodafone Ventures has filed a 13D/A at 5%, and Rakuten Mobile holds 5.3% also under a 13D/A, having trimmed from 7.2%. Founder and CEO Abel Avellan holds 20.8% under a 13D/A, unchanged from his previous filing. These are not passive positions: the 13D designation signals intent to influence or engage with management, and their presence reflects how deeply commercial partners and the founder are embedded in the cap structure. BlackRock recently crossed above 5% (filed October 27) and Vanguard Capital Management initiated a fresh 13G at 5.11% (filed October 30). As always, 13D/G disclosures are event-driven around the 5% threshold and positions may change without a subsequent filing.

The index rebalance calendar adds a mechanical dimension that few notes on ASTS are carrying. ORTEX forecasts a 95% probability that ASTS joins both the MSCI World Small and MSCI USA Small indices at the November 2026 Quarterly Review, with an announcement expected November 11 and a trade date of November 30. The combined inflow from those two additions would be around $1.1 billion from index trackers alone, equivalent to about 2.3 days of normal volume. Running the other way, ORTEX also puts a 95% probability on ASTS being deleted from the MSCI USA index at the same review, carrying roughly $387 million of selling. The net flow is therefore a question of which indices own more of the stock, not a simple directional trade. Additionally, ORTEX puts an 84% probability on ASTS leaving the CRSP US Mid index at the December review if the stock closes below $51.06 at the rank date, a price now 40.5% above current levels. These are forecasts, not announcements, and flows will only materialise if the index provider confirms the changes on November 11.

With earnings scheduled for November 9 and an index announcement expected two days later, the next ten days carry more scheduled catalysts than most weeks offer in a month. The question heading in is whether the combination of a deeply shorted float, mechanically forced index flows, a founder-heavy 13D register, and a cash-intensive business model resolves cleanly or creates further cross-currents in the borrow market.

Stocks in this article

See the live data behind this article on ORTEX.

Open ASTS on ORTEX →

How this article was generated

Generated
3 Nov 2026, 17:31
Data as of
3 Nov 2026, 17:31
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.